These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34540820)

  • 1. Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein.
    Li T; Kuang T; Yang Z; Zhang Q; Zhang W; Fan Y
    Front Cell Dev Biol; 2021; 9():633035. PubMed ID: 34540820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIF-mediated Suppression of DEPTOR Confers Resistance to mTOR Kinase Inhibition in Renal Cancer.
    Doan H; Parsons A; Devkumar S; Selvarajah J; Miralles F; Carroll VA
    iScience; 2019 Nov; 21():509-520. PubMed ID: 31710966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
    Zhang HR; Chen JM; Zeng ZY; Que WZ
    J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
    Zhang H; Chen J; Zeng Z; Que W; Zhou L
    Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway.
    Hu B; Lv X; Gao F; Chen S; Wang S; Qing X; Liu J; Wang B; Shao Z
    Onco Targets Ther; 2017; 10():4379-4391. PubMed ID: 28932123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEPTOR regulates osteogenic differentiation via inhibiting MEG3-mediated activation of BMP4 signaling and is involved in osteoporosis.
    Chen S; Jia L; Zhang S; Zheng Y; Zhou Y
    Stem Cell Res Ther; 2018 Jul; 9(1):185. PubMed ID: 29973283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.
    Vega MI; Shi Y; Frost P; Huerta-Yepez S; Antonio-Andres G; Hernandez-Pando R; Lee J; Jung ME; Gera JF; Lichtenstein A
    Mol Cancer Ther; 2019 Oct; 18(10):1822-1831. PubMed ID: 31395691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
    Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
    Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.
    Yao H; Tang H; Zhang Y; Zhang QF; Liu XY; Liu YT; Gu WT; Zheng YZ; Shang HB; Wang Y; Huang JY; Wei YX; Zhang X; Zhang J; Wu ZB
    Cancer Lett; 2019 Sep; 459():135-144. PubMed ID: 31176743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression.
    Das F; Ghosh-Choudhury N; Lee DY; Gorin Y; Kasinath BS; Choudhury GG
    PLoS One; 2018; 13(11):e0207285. PubMed ID: 30444896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
    Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
    Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
    Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p65 down-regulates DEPTOR expression in response to LPS stimulation in hepatocytes.
    Yu X; Jin D; Yu A; Sun J; Chen X; Yang Z
    Gene; 2016 Sep; 589(1):12-19. PubMed ID: 27179948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEPTOR-related mTOR suppression is involved in metformin's anti-cancer action in human liver cancer cells.
    Obara A; Fujita Y; Abudukadier A; Fukushima T; Oguri Y; Ogura M; Harashima S; Hosokawa M; Inagaki N
    Biochem Biophys Res Commun; 2015 May; 460(4):1047-52. PubMed ID: 25843797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-96-5p Inhibits mTOR/NF-κb Signaling Pathway via DEPTOR in Allergic Rhinitis.
    Zhan JB; Zheng J; Zeng LY; Fu Z; Huang QJ; Wei X; Zeng M
    Int Arch Allergy Immunol; 2021; 182(3):210-219. PubMed ID: 33477144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity.
    Cui D; Dai X; Gong L; Chen X; Wang L; Xiong X; Zhao Y
    Cell Death Dis; 2020 Nov; 11(11):976. PubMed ID: 33184290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis.
    Ding Y; Shan L; Nai W; Lin X; Zhou L; Dong X; Wu H; Xiao M; Zhou X; Wang L; Li T; Fu Y; Lin Y; Jia C; Dai M; Bai X
    Cell Physiol Biochem; 2018; 46(2):520-531. PubMed ID: 29614494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEPTOR in Skeletal Development and Diseases.
    Perez-Tejeiro JM; Csukasi F
    Front Genet; 2021; 12():667283. PubMed ID: 34122519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of DEP domain containing mTOR-interacting protein correlates with poor prognosis in differentiated thyroid carcinoma.
    Pei L; Xie P; Zhou E; Yang Q; Luo Y; Tang Z
    Mol Med Rep; 2011; 4(5):817-23. PubMed ID: 21643629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.